Biocon Of India To Launch Two New Pre-Filled Syringes
This article was originally published in PharmAsia News
India's Biocon says it is ready to launch a new pre-filled syringe device for delivering two of the biotech's kidney and cancer drugs. The syringes are called Erypro Safe for the kidney drug and Nufil Safe for the cancer drug, both launched with California-based Safety Syringes. Both syringes are designed to reduce the amount of pain accompanying an injection, Biocon said. The firm said it plans to set an affordable price on the syringes in India, where pre-filled versions have been rare. (Click here for more
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?